Clinical Trial Update: A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment [Phase 2]

View source ↗

Summary

A Phase 2b study evaluating the safety and efficacy of DUR-928 in alcoholic hepatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Hepatitis

Drugs mentioned

• DUR-928

Snippet

Sponsor: Durect | Conditions: Alcoholic Hepatitis | Phase 2 | Status: COMPLETED